NCT07164846 Effect of Neuro20 Functional Electrical Stimulation Suit on Autonomic Function, Muscle Performance, and Gait
| NCT ID | NCT07164846 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brooks Rehabilitation |
| Condition | Spinal Cord Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-08-05 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-08-05 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research aims to understand the effect of the Neuro20 Functional Electrical Stimulation Suit on autonomic nervous system function, muscle performance, and gait after amputation or neurologic injury.
Eligibility Criteria
Inclusion Criteria: * At least one week post amputation or neurologic injury (i.e. brain injury, stroke, spinal cord injury) and deemed medically stable to participate in rehabilitation * Able to provide Informed Consent by demonstrating the ability to follow a three step command Exclusion Criteria: * Pacemaker / Defibrillator or severe cardiac disease (Class IV according to New York Heart Association Functional Classification) * Implanted medical devices * Active DVT/thrombophlebitis * Active Cancer * Active fever, infection, or acute inflammation * Pregnancy * Epilepsy or uncontrolled seizures or seizure within the last 6 months * Implanted stimulator or pump that cannot be turned off externally * Significant, active wounds in areas stimulated by the suit * Inability to follow a three-step motor command * Bleeding tendency
Contact & Investigator
Mark Bowden, PT, PhD
PRINCIPAL INVESTIGATOR
Brooks Rehabilitation
Frequently Asked Questions
Who can join the NCT07164846 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07164846 currently recruiting?
Yes, NCT07164846 is actively recruiting participants. Contact the research team at hannah.grimes@brooksrehab.org for enrollment information.
Where is the NCT07164846 trial being conducted?
This trial is being conducted at Jacksonville, United States, Tampa, United States.
Who is sponsoring the NCT07164846 clinical trial?
NCT07164846 is sponsored by Brooks Rehabilitation. The principal investigator is Mark Bowden, PT, PhD at Brooks Rehabilitation. The trial plans to enroll 30 participants.